Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

By F. Gaalen, S. Linn-Rasker, W. Venrooij, B. D. Jong, F. Breedveld, C. Verweij, R. Toes, T. Huizinga. Arthritis & Rheumatism, 2004

678 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. (2005, background): “* The following alleles were classified as shared epitope (SE) positive: DRB1*0101, *0102, *0104, *0401, *0404, *0405, *0408, *0413, *0416, *1001, and *1402 ( 4 ).”
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. (2012, positive): “Several studies have shown that ACPAs are among the strongest predictors for bone-erosive disease in RA, strongly suggesting a direct link between autoantibody response in RA and the ability of the disease to elicit structural bone damage (13–16).”